MiTF also controls the expression of Tbx2 and CDK2, which are involved in melanoma proliferation and suppression of senescence [93], [94], [95], in addition to anti-apoptotic genes such as Bcl2 and ML-IAP [96], [97]. Here, BCL2 is linked to melanoma.